Contacts

Investor Relations

Oasmia Pharmaceutical AB
Anders Blom
Executive Vice President
Vallongatan 1
752 28, Uppsala
Sweden
T: +46 18 50 54 40
anders.blom@oasmia.com

Transfer Agent

Bank of New York Mellon Corporation

Auditor

Ernst & Young
Fredrik Norrman

Legal Counsel

Oasmia Pharmaceutical AB
Filippa Strid Eriksson
Vallongatan 1
752 28, Uppsala
Sweden
T: +46 18 50 54 40
filippa.strid-eriksson@oasmia.com